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Vif proteinDeﬁned host-encoded feline APOBEC3 (feA3) cytidine deaminases efﬁciently restrict the replication and
spread of exogenous retroviruses like Feline Immunodeﬁciency Virus (FIV) and Feline Foamy Virus (FFV)
which developed different feA3 counter-acting strategies. Here we characterize the molecular interaction
of FFV proteins with the diverse feA3 proteins. The FFV accessory protein Bet is the virus-encoded defense
factor which is shown here to bind all feA3 proteins independent of whether they restrict FFV, a feature
shared with FIV Vif that induces degradation of all feA3s including those that do not inactivate FIV. In con-
trast, only some feA3 proteins bind to FFV Gag, a pattern that in part reﬂects the restriction pattern detected.
Additionally, one-domain feA3 proteins can homo- and hetero-dimerize in vitro, but a trans-dominant phe-
notype of any of the low-activity feA3 forms on FFV restriction by one of the highly-active feA3Z2 proteins
was not detectable.
© 2012 Elsevier Inc. All rights reserved.Introduction
The replication of exogenous pathogens is often inhibited by speciﬁc
cellular defensemechanisms, e.g. in the formof pathogen-speciﬁc restric-
tion factors (Bieniasz, 2004). APOBEC3 (A3) cytidine deaminases have
been recently shown to efﬁciently restrict the replication and spread of
exogenous and endogenous retroviruses, retroid elements and other, dis-
tantly related viruses (Harris and Liddament, 2004). In face of this cellular
restriction, retroviruses developed different, often highly speciﬁc strate-
gies to counteract this restriction (Chiu and Greene, 2008; Cullen, 2006;
Münk et al., 2010). The ongoing struggle of cellular defense and viral
counter-action results in a dynamic co-evolution of the partners involved
(LaRue et al., 2009). In cats, this resulted in a complexA3 locus that under-
went a dramatic recent expansion resulting in three related feA3Z2 genes
(feA3Z2a, -b, and -c) aswell as one feA3Z3 gene, all encoding one-domain
A3 proteins (Münk et al., 2008). In addition, a two-domain feA3Z2-Z3 cy-
tidine deaminase is expressed by complex read-through transcription
(Münk et al., 2008; Zielonka et al., 2010).ﬁcations and Carcinogenesis,
forschungszentrum Heidelberg
many. Fax: +49 6221 42 4932.
.
rmany.
rights reserved.Identifying viral factors that shaped the cellular repertoire of A3
proteins and their evolution requires a comprehensive understanding
of the viral factors targeted by the restriction system and those
developed by the viruses to circumvent it. Recent studies on Feline
Immunodeﬁciency Virus (FIV) presented evidence that the viral targets
and counter-actions are highly related to that of Human Immunodeﬁ-
ciency Virus (Stern et al., 2010; Wang et al., 2011; Zielonka et al.,
2010). However, little is known about other feline retroviruses that like-
ly played also an important evolutionary role for the Felidae (Löchelt et
al., 2005; Münk et al., 2008). In addition, this active co-evolution also
leads to the establishment of cross-species transmission barriers since
the viral counter-defense is in general ineffective or only partially active
against heterologous restriction factors of non-authentic host species
(Baumann, 2006; Münk et al., 2010; Zielonka et al., 2010).
Spumaretro- or foamy viruses (FVs) are a distinct group of retrovi-
ruses that are promising candidates for the development of novel viral
vectors for gene delivery and vaccination (Rethwilm, 2007; Schwantes
et al., 2003; Trobridge, 2009). Similar to the much better studied lenti-
viruses, FVs have a complex genetic makeup consisting of the canonical
retroviral gag, pol, and env genes and the regulatory bel 1/tas gene
encoding the viral transactivator (Linial, 1999; Rethwilm, 2010). In ad-
dition, the accessory bet gene that is generated via splicing counteracts
cellular A3-mediated restriction and may have a role in particle release
and in establishing viral persistence (Alke et al., 2001; Löchelt et al.,
2005; Russell et al., 2005; Saib et al., 1995). In contrast to the unique
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Fig. 1. The known feA3 proteins interact with wt but not with mutant FFV Bet. A. For
co-IP experiments, 293 T cells were co-transfected with HA-tagged feA3Z2a, -b and
-c expression plasmids and pcDNA3.1 control DNA together with wt pCF-7 and bet
mutant pCF-BetMCSs. Cells were harvested 2 d p.t. and extracts used for co-IP with
HA-speciﬁc antibodies. Co-precipitated proteins were detected by immuno-blotting.
As shown in the top panel, only wt but not mutant Bet-MCS was co-precipitated.
Below, immuno-assays of cell extracts document proper protein expression and
identical loading. B. Similarly, HA-tagged feA3Z2b, -Z3 and -Z2b-Z3 expression plasmids
and pcDNA3.1 control DNA together with wt pCF-7 and betmutant pCF-BetMCS genomes
were co-transfected into 293 T cells. Cell extracts were used for co-IP assays using
HA-speciﬁc antibodies. As shown in the top two panels, only wt but not MCS-mutant
Bet was co-precipitated with all different feA3 forms (the one-domain feA3Z2b and -Z3
forms marked by an arrow co-migrate with the IgG light chains used for co-
precipitation which are also detected by the secondary antibody during immuno-
blotting). Below, immuno-assays of cell extracts document proper expression of Bet and
identical loading. In the panels, the source of antigen (from co-IPs or un-fractionated cell
extracts), the antibody used for immuno-detection and the position of molecular mass
markers are given.
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dividual, the sites of FV replication, the authentic target cell(s), the po-
tential disease association and the extent of virus replication during life-
long persistence are limited at present (Bastone et al., 2003; Linial,
2000; Saib, 2003). In this context, our studies on Feline Foamy Virus
(FFV) replication in vitro but especially in cats with respect to host–
virus interaction and interaction with other pathogens aim at enhanc-
ing understanding of these aspects of FV biology (Alke et al., 2000;
Romen et al., 2006; Schwantes et al., 2003).
Different FVs of non-human primates have the capacity to cross spe-
cies barriers to other primates and pose even a signiﬁcant risk of zoo-
notic, inter-species transmission to humans (Heneine et al., 2003;
Switzer et al., 2004). For instance, the prototypic/human FV isolate
PFV has been shown to be the end-product of a zoonotic transfer of a
chimpanzee FV to humans (Herchenröder et al., 1995). No disease has
been associated with the limited number of well-documented zoonotic
transmissions of FVs to humans (Khan, 2009). The apparent ease of in-
terspecies transmissions of primate FV among primates implies that the
active and extensive co-evolution of host-encoded restriction factors
and the viral counter-defense have been insufﬁcient to establish stable
barriers towards cross-species transmission (Leendertz et al., 2008,
2010.). On the other hand, the control and containment of FV replica-
tion by different restriction systems may explain the apparent apatho-
genicity of FVs in their cognate as well as in their heterologous hosts
(Bastone et al., 2003; Münk et al., 2010; Saib, 2003).
By comparing the APOBEC3-mediated restriction of FFV and FIV and
the viral counter-defense via FFV Bet and FIV Vif, we showed that there
are clear species-speciﬁc differences in APOBEC3-mediated restriction
(Münk et al., 2008). Importantly, we show here that both FIV Vif and
FFV Bet inactivate all known feline APOBEC3 proteins independent of
whether they do or do not restrict the respective virus. Furthermore,
Bet and Vif function by fundamentally different means: FIV Vif (like
primate lentiviral Vif) leads to proteasomal degradation of all feA3
proteins while FFV Bet strongly binds all feA3s without decreasing
their stability. This indicates that a Bet-mediated sequestration, mask-
ing, or the retention of feA3 proteins results in their functional inactiva-
tion. Finally, feA3 proteins bind to FFVGag independent ofwhether they
efﬁciently restrict FFV replication.
Results
Different A3 cytidine deaminases have been recently identiﬁed in
the cat genome and their overall pattern of anti-retroviral activity
against feline lenti-, onco-, and spumaviruses was deﬁned: feA3Z3
and –Z2b-Z3 have only minor effects on FFV replication, the feA3Z2b
and -c isoforms are strongly suppressive while feA3Z2a is less active
(Münk et al., 2008). It was also shown that FFV Bet very efﬁciently coun-
teracts feA3Z2b-mediated restriction by a unique mechanism indepen-
dent of decreasing the stability of the restriction factor (Löchelt et al.,
2005; Münk et al., 2008). Here we thoroughly determine the functional
and physical interaction of the feA3swith proteins of FFV, the feline ret-
rovirus that is strongly affected by these cellular restriction factors. In
addition, we study functional and physical interactions of the different
feA3 proteins.
Interaction of feA3 proteins and FFV Bet
We recently showed that FFV Bet speciﬁcally interacts with
feA3Z2b, the feA3 form that is most potent in restricting FFV
(Löchelt et al., 2005). We thus studied here whether Bet also binds
the other feA3Z2 variants and/or those feA3 proteins that are not ac-
tive against FFV (Münk et al., 2008). For this purpose, 293 T cells were
co-transfected with either wt FFV clone pCF-7 or pCF-BetMCS, an FFV
derivative encoding a full-length but non-functional Bet (Alke et al.,
2001) and with plasmids encoding HA-tagged feA3Z2a, -b, -c forms
(Fig. 1A) or feA3Z2b, -Z3, and –Z2b-Z3 (Fig. 1B). Cell lysates harvested48 h post transfection (p.t.)were subjected to co-immuno-precipitation
(co-IP) using an HA tag-speciﬁc monoclonal antibody. Subsequently,
precipitated proteins were detected by immuno-blotting. While wt
FFV Bet was efﬁciently co-precipitated by all three feA3Z2 iso-forms
(Fig. 1A), the mutant BetMCS carrying heterologous amino acid
sequences in a protein motif directly downstream of the Bel1/Tas cod-
ing sequence (Alke et al., 2001) was not precipitated at all (top panel)
although feA3Z2a to -c expression levels were comparable (Fig. 1A,
third panel from top). The result was not due to different steady-state
140 S. Chareza et al. / Virology 424 (2012) 138–146levels of Bet (second panel from top) or loading differences (Fig. 1A,
bottom panel). In addition, precipitation with a normal mouse serum
instead of the anti-HA serum did not result in precipitation of either
feA3 or Bet proteins (data not shown). Correspondingly, we analyzed
whether feA3Z3 and –Z2b-Z3 similarly interact with Bet (Fig. 1B). Sim-
ilar to feA3Z2b used as positive control, feA3Z3 and –Z2b-Z3 exclusively
interacted with wt but not with mutated Bet (top panel). Precipitation
of feA3 proteins as well as Bet protein levels and overall loading were
comparable between the different samples (Fig. 1B).
The interaction of Bet with the known feA3 proteins is independent
of additional FFV proteins as detected when an FFV Bet-expression plas-
mid devoid of any other FFV proteins was co-expressed with the differ-
ent feA3s (data not shown).FFV Bet does not induce proteolytic degradation of feA3 proteins
We next compared the steady state protein levels of HA epitope-
tagged feA3 proteins in the presence of either FFV Bet or FIV Vif and
compared them to those without any of these viral A3 defense factors.
A codon-optimized and V5-tagged FIV vif that yields enhanced Vif
protein levels (Münk et al., 2008) was used. 293 T cells were har-
vested 2 d p.t. and whole cell lysates were analyzed for the presence
of the different feA3 proteins (Fig. 2, left-hand panel, anti HA anti-
body). While steady-state levels of feA3Z2b, -Z3 and -Z2b-Z3 were
not affected by Bet, the same proteins were undetectable in cells co-
expressing FIV Vif. Comparable expression of Bet as well as Vif was
conﬁrmed by immuno-blotting. These ﬁndings conﬁrm previous
data that FIV Vif induces degradation of all feA3 proteins independent
of whether they do (feA3Z2b-Z3 and -Z3) or do not (feAZ2) suppress
FIV replication (Münk et al., 2008; Stern et al., 2010; Wang et al.,
2011: Zielonka et al., 2010). To conﬁrm that FIV Vif induced proteaso-
mal degradation of feA3 proteins, the above experiment was in
parallel performed in the presence of N-acetyl-Leu-Leu-norleucinalα-HA
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Fig. 2. FFV Bet does not decrease the stability of feA3 proteins while FIV Vif induces prote
proteins in the presence of FFV Bet and FIV Vif, 293 T cells were co-transfected with expre
an FFV Bet plasmid or a plasmid encoding a V5-tagged, codon-optimized FIV Vif. Cells were
antiserum. As shown in the top left-hand panel, co-expression of Bet did not change steady
stark contrast, co-expression of FIV Vif resulted in undetectable levels of HA-tagged feA3Z2b
40 h p.t.) were added to corresponding samples (right-hand panel, marked ALLN) instead o
of Bet was again not affected. However, inhibition of the proteasome in Vif-expressing cells
actin conﬁrmed proper loading of the samples. The antibody used for immuno-detection as(ALLN), an efﬁcient inhibitor of cysteine proteases and the protea-
some (Fig. 2, right-hand panel). As expected, ALLN had no or only
minor effects on feA3 stability in the presence or absence of Bet,
while ALLN at least partially restored feA3Z2b, -Z3 and -Z2b-Z3
when FIV Vif was co-expressed. Parallel studies using MG132 which
more speciﬁcally inhibits proteasomal functions conﬁrmed the
proteasome-mediated degradation of feA3 proteins via FIV Vif but
not via FFV Bet (data not shown).The one-domain feA3Z2 and -Z3 proteins homo- and hetero-multimerize
The single-domain human A3 (huA3) proteins dimerize (Bennett et
al., 2008; Shindo et al., 2003; Shlyakhtenko et al., 2011; Stauch et al.,
2009) and even the two-domain huA3G may have to multimerize in
order to restrict HIV (Huthoff et al., 2009). Importantly, it had been
recently suggested that PFV Bet can interfere with huA3C dimerization
(Perkovic et al., 2009). To determine whether feA3 proteins homo- and
hetero-multimerize, protein pull-down experiments were performed.
Glutathione-S-transferase (GST)-tagged feA3Z2b and -Z3 fusion pro-
teins were expressed and puriﬁed from recombinant bacteria. The
feA3 fusion proteins and a bovine FV (BFV) GST-Env protein used as a
control were incubated with extracts from 293 T cell expressing
feA3Z2b, -Z3, and -Z2b-Z3 or transfected with an empty vector. Bound
proteins were precipitated via the GST–glutathione interaction and
detected by immuno-blotting (Fig. 3). Pull-down experiments in the
absence of additional FFV proteins showed speciﬁc homo- and hetero-
dimeric interaction of the one-domain feA3Z2b and -Z3 proteins
whereas the two-domain feA3Z2b-Z3 did not bind any of the one-
domain feA3 proteins. The speciﬁcity of these interactions was con-
ﬁrmed by the negative controls consisting of feA3-deﬁcient cell extract
or the heterologous GST-tagged BFV Env ectodomain (Romen et al.,
2007) and the positive control showing the feA3-FFV Gag interactions
(see below).+pcDNA3.1 +FFV Bet +FIV Vif
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141S. Chareza et al. / Virology 424 (2012) 138–146No trans-dominant negative effect of any of the feA3 proteins in
co-expression studies
Since the one-domain feA3 proteins show different capacities to sup-
press FFV infectivity (Münk et al., 2008) and since theymay have tomul-
timerize to gain enzymatic activity (Bennett et al., 2008; Shindo et al.,
2003; Shlyakhtenko et al., 2011), we analyzed whether co-transfection
of cells with identical amounts of feA3Z2b together with the other one-
domain feA3 forms and the Bet-deﬁcient FFV genome pCF-BBtr results
in altered levels of FFV restriction. The activity of the strongly restricting
feA3Z2b proteinswas not or onlyminimally affected by expression of the
other feA3 proteins (Fig. 4). The data from three independent assays in-
dicate that there is neither synergism nor antagonism of the one-domain
feA3 proteins when assayed for their effect on FFV.
Interaction of feA3 forms with FFV-Gag
To investigate whether all feA3 proteins interact with FFV-Gag and
to ﬁnd out whether the interaction is RNA-dependent, protein pull-
down analyses were performed. For this purpose, the full-length
FFV gag was expressed as GST-Gag fusion protein in bacteria and
puriﬁed by afﬁnity chromatography using glutathione-coupled aga-
rose beads. The GST-tagged FFV Gag was mixed with 293 T cell lysates
containing or lacking the different HA-tagged feA3 proteins. To deter-
mine the inﬂuence of RNA on the feA3-Gag interactions, pull-down
assays were performed in the presence or absence of 50 μg/ml RNaseA.
Proteins bound to FFV Gag were precipitated via the GST-glutathione
interaction and detected by immuno-blotting using HA tag-speciﬁc an-
tibodies. Consistent with previous data (Löchelt et al., 2005), feA3Z2b
bound Gag while feA3Z2b-Z3 displayed an even stronger afﬁnity to
GST-tagged FFV Gag (Fig. 5A, see also Fig. 3). In contrast, only low-
level interaction of feA3Z3 with FFV-Gag was detectable and there
was no unspeciﬁc interaction with the GST moiety. The interactions offeA3Z2b or -Z2b-Z3 with FFV Gag were only slightly affected by RNaseA
treatment but RNA seemed to stabilize the weak interaction of feAZ3
and Gag. The feA3Z2-family member feA3Z2a also showed a strong and
RNA-independent interaction with FFV-Gag, whereas the weak associa-
tion of feAZ2c with Gag was only detectable without RNaseA (Fig. 5B
and data not shown).
Co-localization of feA3Z2b and FFV Gag
To conﬁrm the Gag-feA3 interaction shown above by another tech-
nique, co-localization studies by confocal microscopy were performed
as recently described (Liu et al., 2011). In these studies, FFV Gag was
detected with a capsid-speciﬁc serum (red, left-hand column), feA3Z2b-
HA was detected by an HA-speciﬁc antibody (green, central column)
and nuclei were stained with Hoechst 33342 (blue). Plasmids encoding
wt FFV Gag with a mostly peri-nuclear and homogeneous or ﬁne-
granular cytoplasmic localization (Fig. 6, second row) and a membrane
targeted myr-Gag with a typical cytoplasmic speckled, membrane, and/
or vacuolar localization (Fig. 6, fourth row, Liu et al., 2011) were used to
transfect HeLa cells together with a plasmid encoding feA3Z2b (as indi-
cated at the right side of the panels). In the absence of Gag, feA3Z2b is
homogenously distributed close to the nucleus (top panel), while
co-expression with both Gag proteins resulted in a ﬁne- or coarse-
granular localization depending on whether it interacted with FFV wt or
myr-Gag (middle and bottom rows). The merge of the Gag and feA3Z2b
staining is shown in the right-hand column as a clear orange to yellow
co-localization of both proteins. The re-distribution of feA3Z2b by
co-expressed wt or myr-Gag clearly conﬁrms molecular interactions of
both proteins.
Replication-deﬁcient, Bet-deleted FFV vectors are restricted by feAZ2b
To determine whether replication-deﬁcient, bet-deleted FFV-vectors
are also restricted by feA3Z2b, the env-bel-deleted β-gal-encoding FFV-
vector pCF-ubi-lacZ trans-complemented with FFV Env was analyzed
(Bastone et al., 2007). 293 T cells were co-transfected with the vector
constructs and either an empty control plasmids or the FFV Bet plasmid
pBC-Bet andwith pfeA3Z2b encoding themost active restriction factor of
FFV as indicated (Fig. 7). Vector titers were determined as β-gal transfer
to CRFK cells which are highly susceptible towards FFV and expressed as
transducing units per ml cell culture supernatant (Bastone et al., 2007).
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142 S. Chareza et al. / Virology 424 (2012) 138–146Co-expression of Bet only slightly decreased vector titers, while feA3Z2b
resulted in a very dramatic decrease of the vector titer. Co-expression of
Bet partially relieved feA3Z2b restriction of the pCF-ubi-lacZ gene trans-
fer vector. Proper expression of FFV Bet and feA3Z2b was conﬁrmed by
immuno-blot analysis of cell extracts (data not shown).
Discussion
In this study, previous reports on the antiviral activity of APOBEC3
cytidine deaminases and their inhibition by the FV Bet protein are
conﬁrmed and substantially extended (Löchelt et al., 2005; Münk et
al., 2008; Russell et al., 2005). In a feline retrovirus model we show
here that all known A3 proteins of cats are bound by FFV Bet but
that only the Z2 domain-containing feA3 restriction factors efﬁciently
interact with FFV Gag in vitrowhichmay be a prerequisite for the spe-
ciﬁc incorporation into viral particles. Comparison of steady state
levels of the feA3 proteins in the presence of either FFV Bet or FIV
Vif revealed that Bet does not induce instability of any of the feA3s
while FIV Vif induces proteasomal degradation of all known feA3
forms. These ﬁndings are in concordance with those obtained for
human and feline lenti- and foamy viruses (Löchelt et al., 2005;
Perkovic et al., 2009; Russell et al., 2005; Stern et al., 2010; Wang et
al., 2011; Zielonka et al., 2010).
The feA3 locus and thus the repertoire of feA3 protein is less com-
plex than that of humans, monkeys or horses but signiﬁcantly moreevolved than that of other placental mammals, for instance mice
and dogs (LaRue et al., 2009; Münk et al., 2008). In analogy to other
A3 proteins and as shown in this study, the feline one-domain A3Z2
and -Z3 proteins homo- and hetero-dimerize which is presumably a
prerequisite for their biologically activity (Bennett et al., 2008;
Shindo et al., 2003; Shlyakhtenko et al., 2011; Stauch et al., 2009).
Since different A3 forms are co-expressed in single cells or organs
(Koning, et al., 2009; Münk et al., 2008; Refsland et al., 2010), the
presence of inactive or low-activity forms may decrease the activity
of highly active A3s. However, corresponding studies described here
did not show trans-dominant negative effects of the less active
feA3-forms on feA3Z2b-mediated restriction of FFV. In pull-down ex-
periments, formation of homo- and heterodimers of the single-
domain feA3 proteins was not inhibited by FFV proteins including
Bet (data not shown) which contrasts recent co-IP experiments
where PFV Bet was shown to prevent human A3C dimerization
(Perkovic et al., 2009).
While the pattern of restriction of the different exogenous feline ret-
roviruses by the feA3 proteins had been published recently (Münk et al.,
2008), functional andmechanistic studies on their interaction with FFV
and a direct comparison to FIV Vif, the phylogenetically unrelated but
functionally equivalent counterpart of lentiviruses had not been per-
formed so far. The data presented here conﬁrm that also non-primate
lentivirus Vif induces proteasomal degradation of host A3 proteins in
contrast to the FV Bet proteins that do not affect steady state levels of
feA3Z2b-HA
DAPI
wt Gag
DAPI
wt Gag
feA3Z2b-HA
DAPI
myr-add-Gag
DAPI
myr-add-Gag
feA3Z2b-HA
DAPI
α-CA α-HA Merge
Fig. 6. Co-localization of feA3Z2b-HA with wt and myristoylated Gag proteins. HeLa cells were transfected with a plasmid encoding HA-tagged feA3Z2b-HA and/or FFV wt and
myr-Gag expression plasmids as indicated on the right side of the image. For the detection of FFV Gag, a capsid-speciﬁc serum was used (red, left-hand column), feA3Z2b-HA
was detected by an HA-speciﬁc antibody (green, central column) and nuclei were stained with Hoechst 33342 (blue). The merge of the Gag and feA3 staining is shown in the
right-hand column. In transfected HeLa cells, feA3Z2b-HA (green) is distributed predominantly in the peri-nuclear region. In the co-transfected cells, feA3 is changing its localization
and it is co-localizing with wt/myr-add-Gag (orange to yellow). The inserted bars represent 5 μm.
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et al., 2005; Stern et al., 2010; Wang et al., 2011; Zielonka et al., 2010).
Thus, induction of proteasomal degradation of A3 proteins is the con-
served mechanism of lentivirus Vif proteins while the FV Bet proteins
studied so far bind a very broad range of A3 proteins of their host spe-
cies which likely leads to A3 inactivation, for instance by interfering
with A3 dimerization and/or particle incorporation (Löchelt et al.,
2005; Perkovic et al., 2009). Similarly, FIV Vif induces degradation of
all major feA3 forms independent of whether they restrict FIV replica-
tion or not. This feature of FIV Vif is in contrast to the situation in HIV-
1 where Vif clearly inactivates human A3DE, -F and -G but does not tar-
get A3A and A3B while susceptibility of the other human A3 forms is
controversial (summarized in Albin and Harris, 2010). The biologicalsigniﬁcance of the breadth of protection by FIV Vif but also the breadth
of feA3 binding by FFV Bet is currently not understood butmay be stud-
ied in transgenic cats similar to those that have been recently estab-
lished (Wongsrikeao et al., 2011). The broad protection against
restriction may reﬂect a much longer host-virus co-evolution of cats
with both feline retroviruses versus the situation in human where HIV
was only recently acquired by men while repeated zoonotic transmis-
sions of simian FVs to human beings have not resulted in the stable es-
tablishment of FVs in the human population (Heneine et al., 2003;
Pecon-Slattery et al., 2008; Sharp and Hahn, 2008; Switzer et al., 2005).
Since the steady state levels of feA3 proteins are not affected by
Bet, protection against restriction is most probably mediated by
Bet-feA3 complex formation as discussed previously (Löchelt et al.,
pCF-ubi-lacZ plus pBC-FFV-env
FFV Bet - + - +
feA3Z2b - - + +
106
105
104
103
102
101
100
FF
U 
/ m
l
Fig. 7. FFV-based replication-deﬁcient vectors are restricted by feA3Z2b. 293 T cells
were co-transfected with the bet- and replication-deﬁcient FFV vector pCF-ubi-lacZ
and an FFV Env expression plasmid and either without any other effecter plasmid or
together with plasmids encoding FFV Bet, feA3Z2b or both (as indicated). Two d p.t.,
cell culture supernatants were assayed for lacZ marker gene transfer using CRFK target
cells. Titers are presented as FFU/ml cell culture supernatant.
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anism of a currently unknown stoichiometry requires much higher
Bet levels than those of lentiviral Vif which initiates an enzymatic
degradation process of the restriction factor(s) (Wang et al., 2011).
In line with this idea, FV Bet proteins are highly expressed in infected
cells and Bet is also a major antigen in infected animals pointing to
a strong expression even in vivo (Alke et al., 2000; Löchelt, 2003;
Romen et al., 2006, 2007). The capacity of FFV Bet to bind feA3Z2
and -Z3 proteins indicates that the binding surface of the A3s is either
highly conserved or that the corresponding domain in Bet is highly
ﬂexible or that different binding surfaces are employed by one or
both interaction partners. The Bet-MCS mutation that fully abrogates
FFV Bet function (Alke et al., 2001) and feA3 binding may destroy a
motif directly involved in feA3 binding or essential for proper func-
tion and folding of Bet.
The breadth of protection of both viral proteins, FIV Vif and FFV
Bet with the cellular A3 restriction machinery points to a complex
co-evolution where all cellular restriction factors are bound and inac-
tivated by either viral protein. At ﬁrst glance, it appears that FIV and
FFV can efﬁciently inactivate the A3-mediated restriction. However,
a distinct degree of restriction might be present and only seen when
wt virus replication in A3-knock-out cats would be analyzed, a scenario
reminiscent of murine A3 and diverse murine retroviruses (Okeoma et
al., 2007; Santiago et al., 2008).
In contrast to Bet, FFV Gag binds in vitromainly to feA3Z2 and the
double-domain feA3Z2b-Z3 indicating that the feA3Z2 domain medi-
ates the interaction with Gag. In addition, the interaction of the one-
domain feA3Z2 and the two-domain feA3Z2-Z3 proteins with FFV-
Gag appears to be independent of the presence of RNA. The genetic
divergence between the different feA3Z2 proteins may account for
the differential binding to FFV Gag with either high (feA3Z2b and
-a) and low (feA3Z2c) binders and thus, Gag binding efﬁciency may
directly correlate with the level of restriction of bet-deﬁcient FFV by
these feA3Z2 forms. Importantly, the interaction of wt or membrane-
targeted Gagwith feA3Z2b is strong enough to lead to the clear redistri-
bution of the restriction factor to the sites of particle assembly which is
probably a prerequisite for feA3 protein packaging into viral particles
(Liu et al., 2011;Münk et al., 2010). Ongoing studies aimed at character-
izing feA3 incorporation into FFV particles indicate that the relative ex-
pression levels of FFV proteins (Gag and Bet) versus feA3 proteins are
crucial for packaging and restriction.
The A3-inactivating function of Bet is essential for FV-replication
since a Bet-deﬁcient foamy virus is not known and even in an ancient,endogenous FV of sloth, traces of the bet/bel2 gene can be found
(Katzourakis et al., 2009; Linial, 1999; Rethwilm, 2010). Provided
that this ancient sloth FV bet/bel2 gene in fact counteracted A3-
mediated restriction, this would be indicative of an extremely long
co-evolution of FVs as the most ancient retroviruses and host-encoded
A3 restriction (Switzer et al., 2005). Thus, studying themolecularmech-
anisms of anti-viral restriction and viral counter-defense should shed
new insights into the evolution of this system and its past and current
contribution to virus replication capacity and virulence as well as path-
ogenicity or apathogenicity, resp.
Material and methods
Cell culture and virological methods
293 T cells and FFV FAB cells used for titration of FFV were propa-
gated as described (Zemba et al., 2000). Transfection of sub-conﬂuent
293 T cells grown in 20 and 60 cm2 dishes with plasmid DNA using a
modiﬁed Calcium-Phosphate method was done as recently described
(Zemba et al., 2000). The infectivity of wt and bet-deﬁcient FFV in
presence of the feA3 variants was assayed by the β-galactosidase-
assay using FFV-FAB cells grown in 24-well plates (Zemba et al.,
2000). In order to inhibit the cellular proteasome, cells were treated
from 12 to 40 h p.t. with 25 μM of the proteasome inhibitor ALLN
(dissolved in DMSO) supplemented to the medium.
Production of the replication-deﬁcient and bet-deleted β-gal-
encoding FFV vector pCF-ubi-lacZ trans-complemented with FFV
Env and quantiﬁcation of marker gene transfer were done as previ-
ously described (Bastone et al., 2007).
Plasmids and DNA transfection
FFVwt andBetmutant plasmids pFeFV-BBtr and pFeFV-MCS and the
eukaryotic FFV Bet expression plasmid have been described previously
(Alke et al., 2001; Zemba et al., 2000). In pFeFV-BBtr, the 387-residue-
wt-Bet is truncated after amino acid 116, whereas in pFeFV-MCS few
residues are exchanged and inserted at the same site (Alke et al.,
2001). To increase gene expression, both Bet mutations were cloned
into the CMV-IE promoter-driven FFV pCF-7 (Schwantes et al., 2002),
resulting in mutants pCF-BBtr and pCF-MCS. Isolation and cloning of
feA3Z2a, -b, -c, feA3Z3 and feA3Z2Z3b forms previously designated
APOBEC3C-a, -b-, -c, feAPOBEC3H and feAPOBEC3CH have been
described previously (Löchelt et al., 2005; Münk et al., 2007, 2008;
Zielonka et al., 2010). In some experiments, a feA3Z3 expression clone
lacking un-translated leader sequences and carrying an Asn to Asp ex-
change of the second feA3Z3 residue was used. Expression plasmids
for FFV wt Gag and myr-Gag (pBC-wtGag and pBC-ScrGag-add, resp.)
have been described recently (Liu et al., 2011).
Bacterial expression vectors for Glutathione-S-transferase (GST)-
tagged FFV Gag and Bet as well as BFV Env have been described
recently (Romen et al., 2006, 2007).
Immuno-precipitation and immuno-blotting
For co-immuno-precipitation (co-IP) of FFV Bet or FFV Bet-MCS
and feA3-variants, 293 T cells were transfected with 4ug of feA3Z2a-
HA, feA3Z2b-HA, feA3Z2c-HA, feA3Z3-HA and feA3Z2b-Z3-HA ex-
pression plasmid and 12ug of pCF-7 or pCF-BetMCS. 2 d p.t., cells
were lysed in TLB (20 mM Tris, pH 7.4, 137 mM NaCl, 10% glycerol,
2 mM EDTA, pH 8, 1% Triton X-100, 50 mM Na+-β-glycerophosphate
and protease inhibitors) and lysates were cleared by centrifugation.
To increase speciﬁcity, the supernatants were pre-incubated with
normal mouse serum (Sigma-Aldrich, Munich) coupled to protein-
G-sepharose (Amersham Bioscience, Uppsala, Sweden) for 60 min.
at 4 °C. After removing the supernatant the beads were washed 3
times with TLB. The supernatants were incubated with anti-HA-IgG
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for 60 min. at 4 °C and washed three times with TLB. After boiling
in electrophoresis sample buffer, samples of the preincubation and the
immuno-precipitation were subjected to SDS-PAGE and immuno-
blotting (Alke et al., 2001). Detection of feA3Z2 variants was performed
withmonoclonal anti-HA-IgG (Covance,Münster). Detection of FFV-Bet
with the FFV Bel2/Bet antiserum has been described previously (Alke et
al., 2001). Membranes were incubated with horseradish peroxidase-
conjugated secondary antibodies (Amersham Pharmacia, Sigma-
Aldrich) and visualized by enhanced chemiluminescence (ECL, Amer-
sham Pharmacia). For immuno-blotting of the lysates, identical
amounts of cell extractswere used as determined by Roti-Quant protein
quantiﬁcation (Roth, Karlsruhe, Germany).
Immuno-ﬂuorescence and confocal microscopy
HeLa cells were grown on coverslips and transfected with 1 μg FFV
Gag (wt or myr) expression plasmid and 1 μg of pfeA3Z2b-HA as de-
scribed (Liu et al., 2011). In brief, 2 d p.t., cells were ﬁxed with 3%
paraformaldehyde in PBS for 15 min. and permeabelized with 0.1%
Triton-X-100 for 7 min. Cells were incubated with guinea pig anti-
CA serum (1:2,000) and mouse anti-HA antibody (Abcam plc, Cam-
bridge, UK, 1:500) diluted in 3% BSA in PBS. As secondary antibodies
goat anti-guinea pig Alexa Fluor 568 and goat anti-mouse Alexa
Fluor 488 (Invitrogen, Karlsruhe, Germany) were used in dilutions
1:16,000 and 1:2,000 respectively. Nuclei were detected with
Hoechst 33342 (1:2000). Images from the center of the cell were
taken using a Zeiss LSM700 confocal microscope.
Protein pull-down assays
For pull-down-assays of the feA3 variants with FFV-Gag, FFV-Bet,
and feA3 proteins, 293 T cells were transfected with 20ug of pfeA3
expression plasmids encoding the corresponding feA3 forms. 2 d p.t.,
cells were lysed in TLB and lysates were cleared by centrifugation. The
sample supernatants were then incubated with GST-tagged FFV-Gag,
feA3Z2b or -Z3 expression proteins coupled to Glutatione-S-sepharose
according to the manufacturers' instruction (Sigma-Aldrich). The sam-
ples were incubated for 60 min. at 4 °C and washed three times with
PBS/1%TX100. For negative control, the samples were incubated with
GST alone or GST-coupled BFV Env (Romen et al., 2007). After boiling
in electrophoresis sample buffer, samples were subjected to SDS-PAGE
and immuno-blotting (Alke et al., 2001).
Acknowledgments
We thank Lutz Gissmann for continuous support and Anne Bleiholder,
Timo Kehl and Janet Lei (all DKFZ) for critically reading the manuscript.
Support by theDKFZ LightMicroscopy Facility is gratefully acknowledged.
M.L was supported by a Waltraud Lewenz Foundation PhD fellowship to
S.C. and C.M. is supported by the Heinz-Ansmann Foundation for AIDS
Research.
References
Albin, J.S., Harris, R.S., 2010. Interactions of host APOBEC3 restriction factors with HIV-1
in vivo: implications for therapeutics. Expert Rev. Mol. Med. 12, e4.
Alke, A., Schwantes, A., Zemba, M., Flügel, R.M., Löchelt, M., 2000. Characterization of
the humoral immune response and virus replication in cats experimentally
infected with feline foamy virus. Virology 275 (1), 170–176.
Alke, A., Schwantes, A., Kido, K., Flötenmeyer, M., Flügel, R.M., Löchelt, M., 2001. The bet
gene of feline foamy virus is required for virus replication. Virology 287 (2),
310–320.
Bastone, P., Truyen, U., Löchelt, M., 2003. Potential of zoonotic transmission of non-
primate foamy viruses to humans. J. Vet. Med. B Infect. Dis. Vet. Public Health 50
(9), 417–423.
Bastone, P., Romen, F., Liu, W., Wirtz, R., Koch, U., Josephson, N., Langbein, S., Löchelt,
M., 2007. Construction and characterization of efﬁcient, stable and safe
replication-deﬁcient foamy virus vectors. Gene Ther. 14 (7), 613–620.Baumann, J.G., 2006. Intracellular restriction factors in mammalian cells—an ancient
defense system ﬁnds a modern foe. Curr. HIV Res. 4 (2), 141–168.
Bennett, R.P., Salter, J.D., Liu, X., Wedekind, J.E., Smith, H.C., 2008. APOBEC3G subunits
self-associate via the C-terminal deaminase domain. J. Biol. Chem. 283 (48),
33329–33336.
Bieniasz, P.D., 2004. Intrinsic immunity: a front-line defense against viral attack. Nat.
Immunol. 5 (11), 1109–1115.
Chiu, Y.L., Greene, W.C., 2008. The APOBEC3 cytidine deaminases: an innate defensive
network opposing exogenous retroviruses and endogenous retroelements. Annu.
Rev. Immunol. 26, 317–353.
Cullen, B.R., 2006. Role and mechanism of action of the APOBEC3 family of antiretroviral
resistance factors. J. Virol. 80 (3), 1067–1076.
Harris, R.S., Liddament, M.T., 2004. Retroviral restriction by APOBEC proteins. Nat. Rev.
Immunol. 4 (11), 868–877.
Heneine, W., Schweizer, M., Sandstrom, P., Folks, T., 2003. Human infection with foamy
viruses. Curr. Top. Microbiol. Immunol. 277, 181–196.
Herchenröder, O., Turek, R., Neumann-Haefelin, D., Rethwilm, A., Schneider, J., 1995.
Infectious proviral clones of chimpanzee foamy virus (SFVcpz) generated by long
PCR reveal close functional relatedness to human foamy virus. Virology 214 (2),
685–689.
Huthoff, H., Autore, F., Gallois-Montbrun, S., Fraternali, F., Malim,M.H., 2009. RNA-dependent
oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog. 5 (3),
e1000330.
Katzourakis, A., Gifford, R.J., Tristem, M., Gilbert, M.T., Pybus, O.G., 2009. Macroevolu-
tion of complex retroviruses. Science 325 (5947), 1512.
Khan, A.S., 2009. Simian foamy virus infection in humans: prevalence and manage-
ment. Expert Rev. Anti Infect. Ther. 7 (5), 569–580.
Koning, F.A., Newman, E.N., Kim, E.Y., Kunstman, K.J., Wolinsky, S.M., Malim, M.H.,
2009. Deﬁning APOBEC3 expression patterns in human tissues and hematopoietic
cell subsets. J. Virol. 83 (18), 9474–9485.
LaRue, R.S., Andresdottir, V., Blanchard, Y., Conticello, S.G., Derse, D., Emerman, M.,
Greene, W.C., Jonsson, S.R., Landau, N.R., Löchelt, M., Malik, H.S., Malim, M.H.,
Münk, C., O'Brien, S.J., Pathak, V.K., Strebel, K., Wain-Hobson, S., Yu, X.F., Yuhki,
N., Harris, R.S., 2009. Guidelines for naming nonprimate APOBEC3 genes and
proteins. J. Virol. 83 (2), 494–497.
Leendertz, F.H., Zirkel, F., Couacy-Hymann, E., Ellerbrok, H., Morozov, V.A., Pauli, G.,
Hedemann, C., Formenty, P., Jensen, S.A., Boesch, C., Junglen, S., 2008. Interspecies
transmission of simian foamy virus in a natural predator–prey system. J. Virol. 82
(15), 7741–7744.
Leendertz, S.A., Junglen, S., Hedemann, C., Goffe, A., Calvignac, S., Boesch, C., Leendertz,
F.H., 2010. High prevalence, coinfection rate, and genetic diversity of retroviruses
in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park,
Cote d'Ivoire. J. Virol. 84 (15), 7427–7436.
Linial, M.L., 1999. Foamy viruses are unconventional retroviruses. J. Virol. 73 (3),
1747–1755.
Linial, M., 2000. Why aren't foamy viruses pathogenic? Trends Microbiol. 8 (6),
284–289.
Liu, Y., Kim, Y.-B., Löchelt, M., 2011. N-terminally myristoylated Feline Foamy Virus Gag
allows Env-independent budding of sub-viral particles. Viruses 3, 2223–2237.
Löchelt, M., 2003. Foamy virus transactivation and gene expression. Curr. Top.
Microbiol. Immunol. 277, 27–61.
Löchelt, M., Romen, F., Bastone, P., Muckenfuss, H., Kirchner, N., Kim, Y.B., Truyen, U.,
Rösler, U., Battenberg, M., Saib, A., Flory, E., Cichutek, K., Münk, C., 2005. The
antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet
protein. Proc. Natl. Acad. Sci. U. S. A. 102 (22), 7982–7987.
Münk, C., Zielonka, J., Constabel, H., Kloke, B.P., Rengstl, B., Battenberg, M., Bonci, F.,
Pistello, M., Löchelt, M., Cichutek, K., 2007. Multiple restrictions of human
immunodeﬁciency virus type 1 in feline cells. J. Virol. 81 (13), 7048–7060.
Münk, C., Beck, T., Zielonka, J., Hotz-Wagenblatt, A., Chareza, S., Battenberg, M., Thielebein,
J., Cichutek, K., Bravo, I.G., O'Brien, S.J., Löchelt, M., Yuhki, N., 2008. Functions,
structure, and read-through alternative splicing of feline APOBEC3 genes. Genome
Biol. 9 (3), R48.
Münk, C., Hechler, T., Chareza, S., Löchelt, M., 2010. Restriction of feline retroviruses:
lessons from cat APOBEC3 cytidine deaminases and TRIM5alpha proteins. Vet.
Immunol. Immunopathol. 134 (1–2), 14–24.
Okeoma, C.M., Lovsin, N., Peterlin, B.M., Ross, S.R., 2007. APOBEC3 inhibits mouse
mammary tumour virus replication in vivo. Nature 445 (7130), 927–930.
Pecon-Slattery, J., Troyer, J.L., Johnson, W.E., O'Brien, S.J., 2008. Evolution of feline-
immunodeﬁciency virus in Felidae: implications for human health and wildlife
ecology. Vet. Immunol. Immunopathol. 123 (1–2), 32–44.
Perkovic, M., Schmidt, S., Marino, D., Russell, R.A., Stauch, B., Hofmann, H., Kopietz, F.,
Kloke, B.P., Zielonka, J., Strover, H., Hermle, J., Lindemann, D., Pathak, V.K., Schneider,
G., Löchelt, M., Cichutek, K., Münk, C., 2009. Species-speciﬁc inhibition of APOBEC3C
by the prototype foamy virus protein bet. J. Biol. Chem. 284 (9), 5819–5826.
Refsland, E.W., Stenglein, M.D., Shindo, K., Albin, J.S., Brown, W.L., Harris, R.S., 2010.
Quantitative proﬁling of the full APOBEC3 mRNA repertoire in lymphocytes and
tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38 (13),
4274–4284.
Rethwilm, A., 2007. Foamy virus vectors: an awaited alternative to gammaretro- and
lentiviral vectors. Curr Gene Ther 7 (4), 261–271.
Rethwilm, A., 2010. Molecular biology of foamy viruses. Med. Microbiol. Immunol. 199
(3), 197–207.
Romen, F., Pawlita, M., Sehr, P., Bachmann, S., Schröder, J., Lutz, H., Löchelt, M., 2006.
Antibodies against Gag are diagnostic markers for feline foamy virus infections
while Env and Bet reactivity is undetectable in a substantial fraction of infected
cats. Virology 345 (2), 502–508.
146 S. Chareza et al. / Virology 424 (2012) 138–146Romen, F., Backes, P., Materniak, M., Sting, R., Vahlenkamp, T.W., Riebe, R., Pawlita, M.,
Kuzmak, J., Löchelt, M., 2007. Serological detection systems for identiﬁcation of
cows shedding bovine foamy virus via milk. Virology 364 (1), 123–131.
Russell, R.A., Wiegand, H.L., Moore, M.D., Schafer, A., McClure, M.O., Cullen, B.R., 2005.
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of
innate antiretroviral defense factors. J. Virol. 79 (14), 8724–8731.
Saib, A., 2003. Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 277,
197–211.
Saib, A., Koken, M.H., van der Spek, P., Peries, J., de The, H., 1995. Involvement of a
spliced and defective human foamy virus in the establishment of chronic infection.
J. Virol. 69 (9), 5261–5268.
Santiago, M.L., Montano, M., Benitez, R., Messer, R.J., Yonemoto, W., Chesebro, B.,
Hasenkrug, K.J., Greene, W.C., 2008. Apobec3 encodes Rfv3, a gene inﬂuencing neu-
tralizing antibody control of retrovirus infection. Science 321 (5894), 1343–1346.
Schwantes, A., Ortlepp, I., Löchelt, M., 2002. Construction and functional characteriza-
tion of feline foamy virus-based retroviral vectors. Virology 301 (1), 53–63.
Schwantes, A., Truyen, U., Weikel, J., Weiss, C., Löchelt, M., 2003. Application of chimeric
feline foamy virus-based retroviral vectors for the induction of antiviral immunity
in cats. J. Virol. 77 (14), 7830–7842.
Sharp, P.M., Hahn, B.H., 2008. AIDS: prehistory of HIV-1. Nature 455 (7213),
605–606.
Shindo, K., Takaori-Kondo, A., Kobayashi, M., Abudu, A., Fukunaga, K., Uchiyama, T.,
2003. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation
of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.
J. Biol. Chem. 278 (45), 44412–44416.
Shlyakhtenko, L.S., Lushnikov, A.Y., Li, M., Lackey, L., Harris, R.S., Lyubchenko, Y.L., 2011.
Atomic force microscopy studies provide direct evidence for dimerization of the
HIV restriction factor APOBEC3G. J. Biol. Chem. 286 (5), 3387–3395.Stauch, B., Hofmann, H., Perkovic, M., Weisel, M., Kopietz, F., Cichutek, K., Münk, C.,
Schneider, G., 2009. Model structure of APOBEC3C reveals a binding pocket modu-
lating ribonucleic acid interaction required for encapsidation. Proc. Natl. Acad. Sci.
U. S. A. 106 (29), 12079–12084.
Stern, M.A., Hu, C., Saenz, D.T., Fadel, H.J., Sims, O., Peretz, M., Poeschla, E.M., 2010. Productive
replication of Vif-chimeric HIV-1 in feline cells. J. Virol. 84 (14), 7378–7395.
Switzer, W.M., Bhullar, V., Shanmugam, V., Cong, M.E., Parekh, B., Lerche, N.W., Yee, J.L.,
Ely, J.J., Boneva, R., Chapman, L.E., Folks, T.M., Heneine, W., 2004. Frequent simian
foamy virus infection in persons occupationally exposed to nonhuman primates.
J. Virol. 78 (6), 2780–2789.
Switzer, W.M., Salemi, M., Shanmugam, V., Gao, F., Cong, M.E., Kuiken, C., Bhullar, V.,
Beer, B.E., Vallet, D., Gautier-Hion, A., Tooze, Z., Villinger, F., Holmes, E.C., Heneine,
W., 2005. Ancient co-speciation of simian foamy viruses and primates. Nature 434
(7031), 376–380.
Trobridge, G.D., 2009. Foamy virus vectors for gene transfer. Expert. Opin. Biol. Ther. 9
(11), 1427–1436.
Wang, J., Zhang, W., Lv, M., Zuo, T., Kong, W., Yu, X., 2011. Identiﬁcation of a cullin5-
elonginB-elonginC E3 complex in the degradation of FIV Vif-mediated feline APO-
BEC3 proteins. J. Virol.. doi:10.1128/JVI-05218-11
Wongsrikeao, P., Saenz, D., Rinkoski, T., Otoi, T., Poeschla, E., 2011. Antiviral restriction
factor transgenesis in the domestic cat. Nat. Methods 8 (10), 853–859.
Zemba, M., Alke, A., Bodem, J., Winkler, I.G., Flower, R.L., Pfrepper, K., Delius, H., Flügel,
R.M., Löchelt, M., 2000. Construction of infectious feline foamy virus genomes: cat
antisera do not cross-neutralize feline foamy virus chimera with serotype-speciﬁc
Env sequences. Virology 266 (1), 150–156.
Zielonka, J., Marino, D., Hofmann, H., Yuhki, N., Löchelt, M., Münk, C., 2010. Vif of feline
immunodeﬁciency virus from domestic cats protects against APOBEC3 restriction
factors from many felids. J. Virol. 84 (14), 7312–7324.
